Category Archives: News

SOM Biotech is awarded a grant from CDTI to start clinical trials with a drug inhibitor of SARS- COV-2 replication

SOM Biotech ends 2020 with an advanced and robust pipeline

SOM Biotech has been granted €340,000.00 from the Center for Industrial Technological Development (CDTI, Spain), within the extraordinary call for grants for R&D projects to face the COVID-19 health emergency. With these funds, SOM Biotech will initiate clinical trials for the development of a new eravacycline-based therapy for the treatment of COVID-19. Eravacycline is an …

The pandemic will trigger investment in biotechnology: the most relevant Spanish startups and the sectors with the greatest potential

Business insider. The most relevant Spanish startups

Business Insider Spain published the article “The pandemic will trigger investment in biotechnology: the most relevant Spanish startups and the sectors with the greatest potential.”  With biotech companies leading the search for a COVID-19 vaccine, improving antibody detection and diagnosis systems, and searching for new treatments, everything indicates that the sector will emerge stronger and …

SOM Biotech appoints Alain Duguet PhD as Head of Chemical Manufacturing and Control

SOM Biotech ends 2020 with an advanced and robust pipeline

SOM Biotech announces the appointment of Alain Duguet Ph.D. as Head of Chemical Manufacturing and Control. Alain Duguet Ph.D. has joined SOM Biotech assuming responsibility for the company´s pharmaceutical development, product manufacturing, and control and compliance with quality requirements. Alain Duguet has extensive experience in pharmaceutical development, from the setting of analytical methods, the testing …

SOM Biotech attended the BIO International Convention 2020

SOM Biotech ends 2020 with an advanced and robust pipeline

SOM Biotech attended the BIO International Convention 2020 in its virtual format “BIO Digital” on June 8th – 12th. The virtual gathering, one of the most relevant venues for the biotech industry worldwide, allowed SOM biotech to hold more than 70 meetings with key potential business partners and identify opportunities for future drug discovery and …

SOM Biotech keynote speaker at the Euronext webinar

SOM Biotech ends 2020 with an advanced and robust pipeline

SOM Biotech participated in the Euronext webinar “Finance your tech company´s growth through capital markets” next June 25th. Raul Insa, CEO of SOM Biotech, was a keynote speaker sharing his experience and views on financing alternatives for a biotech company. Raul Insa: “As CEO and founding partner of a growing biotech company, I have led …

The desperate use of drugs against coronavirus should be rationalized – Press release El PAÍS

SOM Biotech reoriented its capabilities to search for the treatments of COVID-19. Raúl Insa, CEO of SOM Biotech, acknowledges that he had never thought of using his technology to find treatment for infectious disease, but the situation is exceptional. “Our technology works based on chemical structure and we are looking for products available on the …

We have positioned ourselves as a reference company in drug repositioning – Interview of Raúl Insa for “Actualidad Economica”

Interview of Raúl Insa for "Actualidad Economica"

“Actualidad Economica,” the dean magazine of the Spanish economic press, published the Interview of Raúl Insa, where he describes how SOM Biotech positioned itself as a reference company in drug repurposing. In the interview with the magazine, Raúl tells about SOM Biotech’s creation, focus, and objectives of the company. He outlines the main development pipeline …

SOM Biotech announces in vitro confirmation of three drug candidates for COVID-19 in collaboration with the Ewha Womans University

SOM Biotech ends 2020 with an advanced and robust pipeline

SOM Biotech announces the in vitro validation of three drug candidates as new therapies for the treatment of COVID-19. The three candidates inhibit the main protease of SARS-CoV-2 and therefore the replication of the virus. Clinical studies with the three candidates can be initiated immediately. SOM Biotech has applied its artificial intelligence-based screening technology (SOMAIPRO) …

SUBCRIBE TO OUR NEWSLETTER

    Name*
    Email*


    I confirm that by completing this form I have used only personal data about myself and that they are true and up-to-date.
    SOM INNOVATION BIOTECH, S.A. is responsible for the processing of my personal data to manage the newsletter service requested through the form, as well as to track the receipt of these through tracking technologies. The Privacy Policy tells me how I can exercise my rights of access, rectification, deletion, limitation, portability and opposition.